Related Experiment Video
Updated: Jun 19, 2025
06:08
A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
23.4K
Clinical Management of Primary Aldosteronism: An Update
Gian Paolo Rossi1, Federico Bernardo Rossi2, Chiara Guarnieri1
1Internal and Emergency Medicine, Department of Medicine, DIME University of Padua, Italy (G.P.R., C.G., G.R., T.M.S.).
Hypertension (Dallas, Tex. : 1979)
|July 24, 2024
Summary
Primary aldosteronism (PA) is an overlooked cause of hypertension. Early detection and treatment, especially for unilateral PA, can cure hypertension and prevent cardiovascular events.
Area of Science:
- Endocrinology
- Cardiology
- Nephrology
Background:
- Primary aldosteronism (PA) is a prevalent yet underdiagnosed secondary cause of arterial hypertension.
- PA significantly increases the risk of cardiovascular events, including atrial fibrillation, stroke, and myocardial infarction.
- Early diagnosis and treatment of PA are crucial for preventing long-term cardiovascular complications.
Purpose of the Study:
- To provide an update on the management of primary aldosteronism.
- To emphasize the need for increased awareness and improved screening strategies for PA.
- To offer recommendations for drug treatment and alternative strategies to adrenal vein sampling.
Main Methods:
- Review of recent studies, including the AVIS-2 study.
- Analysis of four decades of clinical experience.
- Consideration of the latest clinical guidelines for PA management.
Main Results:
- Unilateral PA, when treated surgically, can lead to hypertension cure and prevention of cardiovascular events.
- Young patients and those with resistant hypertension benefit most from early PA diagnosis.
- Adrenal vein sampling, while key for unilateral PA identification, is technically demanding and often unavailable.
Conclusions:
- Implementing simplified diagnostic algorithms for PA is necessary.
- Strategies to avoid adrenal vein sampling should be developed for settings where it is unavailable.
- Improved detection and management of PA can significantly reduce cardiovascular morbidity and mortality.
Related Concept Videos
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
414
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
414
01:27Adrenal Gland Disorders
1.5K
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
1.5K
01:25Antihypertensive Drugs: Direct Renin Inhibitors
528
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
528
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
495
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
495
01:17Antihypertensive Drugs: Action of β1 Blockers
396
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
396
01:33Hormonal Regulation
33.0K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
33.0K